Dermatomyositis and polymyositis (myositis) trials in Denmark

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  Where

  Copenhagen Oe

  Age

  18 years and over

  People

  240 worldwide

  Run by

  argenx

  See details and how to joinNCT05979441 · EU 2022-502851-79-00
• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  Where

  Aarhus N, Copenhagen Oe, Odense C

  Age

  18 years and over

  People

  84 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2023-504022-19-01
• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  Where

  Aarhus N, Copenhagen, Odense C

  Age

  18 years to 75 years

  People

  240 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06455449
• No phaseNot yet taking people in Denmark
  Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric Setting

  Where

  Aarhus

  Age

  6 years to 18 years

  People

  70

  Run by

  Aarhus University Hospital

  See details and how to joinNCT07349667